QBE INSURANCE GROUP LIMITED (QBE)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

QBE

QBE - QBE INSURANCE GROUP LIMITED

FNArena Sector : Insurance
Year End: December
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX20 | ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

QBE Insurance Group is an Australian insurance company operating in North America, Europe, Australia & New Zealand and the Asia Pacific region. It was listed in 1973 following the merger of three companies whose names represent the letters of the combined company.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$22.92

24 Sep
2026

-0.090

OPEN

$23.03

-0.39%

HIGH

$23.16

2,316,054

LOW

$22.89

TARGET
$25.33 10.5% upside
Franking for last dividend paid out: 30%
OTHER COMPANIES IN THE SAME SECTOR
AUB . FCL . GDG . HLI . IAG . MPL . NHF . NOL . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
QBE: 1
Title FY26
Forecast
FY27
Forecast
EPS (cps) 219.4 xxx
DPS (cps) 98.7 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 10.5 xxx
Dividend Yield 4.3% xxx
Div Pay Ratio(%) 45.0% xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 6.86%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

4.75

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

$ 

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 24/08 - ex-div 33.00c (franking 30%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx219.1
DPS All xxxxxxxxxxxxxxx109.0
Sales/Revenue xxxxxxxxxxxxxxx37,399.9 M
Book Value Per Share xxxxxxxxxxxxxxx1,162.1
Net Operating Cash Flow xxxxxxxxxxxxxxx6,549.2 M
Net Profit Margin xxxxxxxxxxxxxxx8.94 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx18.99 %
Return on Invested Capital xxxxxxxxxxxxxxx15.40 %
Return on Assets xxxxxxxxxxxxxxx4.58 %
Return on Equity xxxxxxxxxxxxxxx19.21 %
Return on Total Capital xxxxxxxxxxxxxxx20.92 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx5,263.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx1,371 M
Long Term Debt xxxxxxxxxxxxxxx4,523 M
Total Debt xxxxxxxxxxxxxxx5,893 M
Goodwill - Gross xxxxxxxxxxxxxxx2,368 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx2,803 M
Price To Book Value xxxxxxxxxxxxxxx1.71

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx209.4 M
Capex % of Sales xxxxxxxxxxxxxxx0.56 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx2,756 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx51,062 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.4

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

16/09/2026

3

Neutral

$24.20

5.58%

Citi considers entry price increasingly important across Australian and New Zealand insurers, given solid but modest growth prospects and broadly fair valuations.

General insurers are expected to deliver relatively stable underlying margins, modest revenue growth and strong capital generation. It's felt Insurance Australia Group and Suncorp Group offer downside protection and potential reported-margin upside.

Elsewhere, Citi believes QBE Insurance may offer stronger organic growth.

Among private health insurers, Medibank Private's near-term outlook appears more certain than nib Holding’s, although its valuation is higher and growth remains subdued, the analysts explain.

Insurance Australia Group and AUB Group are Citi’s preferred sector exposures, with Buy ratings.

For QBE Insurance: Neutral rating and $24.20 target.

FORECAST
Citi forecasts a full year FY26 EPS of 205.14 cents.
Citi forecasts a full year FY27 EPS of 213.81 cents.

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

18/08/2026

4

Downgrade to Underweight from Neutral

$20.30

-11.43%

Jarden downgrades to an Underweight rating for QBE Insurance with its target price decreased to $20.30 from $21.30 amid concerns regarding earnings sustainability and underlying margin pressures.

The 1H26 reported combined operating ratio of 92.8% masked an underlying ratio of 94.6%, leaving the bridge to achieving unchanged FY26 guidance of 92.5% reliant on benign catastrophe activity, substantial cost reductions, reserve releases, and avoiding further Middle East losses.

Investors face growing divergence between premium rates and claims inflation against a backdrop of record industry capital.

While management points to portfolio optimisation, the analyst views this strategy as increasingly challenging to execute as competing insurers similarly reallocate capital towards casualty and specialty product lines.

The broker's estimates reflect execution risks surrounding underwriting margins despite the insurer delivering strong performance across recent periods.

QBE STOCK CHART